Orbimed Advisors Llc Sells 860,123 Shares of Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) Stock

Bitwise MARA Option Income Strategy ETF (NYSEARCA:IMRA) major shareholder Orbimed Advisors Llc sold 860,123 shares of the stock in a transaction that occurred on Monday, June 22nd. The shares were sold at an average price of $45.36, for a total transaction of $39,015,179.28. Following the transaction, the insider owned 219,405 shares in the company, valued at approximately $9,952,210.80. This trade represents a 79.68% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Large shareholders that own at least 10% of a company’s stock are required to disclose their transactions with the SEC.

Orbimed Advisors Llc also recently made the following trade(s):

• On Monday, June 15th, Orbimed Advisors Llc sold 281,408 shares of Bitwise MARA Option Income Strategy ETF stock. The stock was sold at an average price of $45.02, for a total transaction of $12,668,988.16.

Bitwise MARA Option Income Strategy ETF Trading Up 0.4%

NYSEARCA:IMRA opened at $17.09 on Friday. The company has a market cap of $3.25 million, a PE ratio of 341.80 and a beta of 2.88. The company has a 50 day simple moving average of $16.73 and a two-hundred day simple moving average of $15.73. Bitwise MARA Option Income Strategy ETF has a 12 month low of $11.99 and a 12 month high of $54.94.

About Bitwise MARA Option Income Strategy ETF

IMARA Inc, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develops IMR-261, an oral and clinical-ready activator of nuclear factor erythroid 2–related factor 2 for the treatment of hemoglobinopathies, iron disorders, and potentially other areas.